Skip to main content
JOURNAVX 50 mg/1 tablet, film coated by Vertex Pharmaceuticals Incorporated
JOURNAVX, 50 mg/1, tablet, film coated Drug class: Sodium Channel Blocker. Available on prescription only. Listed by Vertex Pharmaceuticals Incorporated.
Prescription only

JOURNAVX

Suzetrigine

Listed by Vertex Pharmaceuticals Incorporated

Strength
50 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Sodium Channel Blocker

What it contains

  • Suzetrigine 50 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Sodium Channel Blocker
Approval route NDA — original brand approval
NDC code 51167-548
FDA application NDA219209
RxNorm concept 2704833
Package sizes listed 4
Marketed since January 2025

Other products containing Suzetrigine

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

JOURNAVX

Suzetrigine

Strength
50 mg/1
Form
Tablet, Film Coated
Class
Sodium Channel Blocker
Rx only

Sportpharm LLC

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.